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Background: The accurate measurement of physical activity is crucial to understanding the relationship
between physical activity and disease prevention and treatment.
Objective: The primary purpose of this study was to investigate the validity and reliability of the activPAL
physical activity monitor in measuring step number and cadence.
Methods: The ability of the activPAL monitor to measure step number and cadence in 20 healthy adults
(age 34.5¡6.9 years; BMI 26.8¡4.8 (mean¡SD)) was evaluated against video observation.
Concurrently, the accuracy of two commonly used pedometers, the Yamax Digi-Walker SW-200 and
the Omron HJ-109-E, was compared to observation for measuring step number. Participants walked on a
treadmill at five different speeds (0.90, 1.12, 1.33, 1.56, and 1.78 m/s) and outdoors at three self
selected speeds (slow, normal, and fast).
Results: At all speeds, inter device reliability was excellent for the activPAL (ICC (2,1)>0.99) for both step
number and cadence. The absolute percentage error for the activPAL was ,1.11% for step number and
cadence regardless of walking speed. The accuracy of the pedometers was adversely affected by slow
walking speeds.
Conclusion: The activPAL monitor is a valid and reliable measure of walking in healthy adults. Its accuracy
is not influenced by walking speed. The activPAL may be a useful device in sports medicine.
L
ack of physical activity has been recognised as a major
underlying cause of death, disease, and disability.1
Physical activity helps in the prevention of certain
diseases and favourable effects of regular physical activity
have been reported in individuals suffering from chronic
diseases such as type II diabetes mellitus, cardiovascular
disease, obesity, and certain cancers.2 3 Several physical
activity guidelines have been developed to reduce the risk
of developing specific diseases. However, the most commonly
cited guideline is directed at sedentary adults. This recom-
mends 30 min of moderate intensity physical activity on
most, preferably all, days of the week.4 The activity may be
achieved in a single session or accumulated in 10 min bouts
throughout the day.5 Activity guidelines specify that time and
intensity are important factors which should be considered
when selecting a valid and reliable device to measure
walking. The accurate measurement of activity is needed to
better establish the relationship between physical activity and
health.6
In order to provide objective measures of walking, a
number of measuring devices have been employed, the most
simple of these being waist worn pedometers. Due to their
low cost and ease of use, they are attractive to researchers,
clinicians, and individuals interested in their personal activity
levels. Pedometers display cumulative step number giving the
user a daily tally. This total may provide a person with a
target to aim for but gives no indication as to when in the day
the wearer was active, how long each walk lasted, or the
intensity (for example, cadence) of the walk. Additionally,
waist worn pedometer accuracy is compromised by slow
walking speeds7–14 and obesity.15–17 The poor accuracy of waist
mounted pedometers in recording slow walking may be a
serious limitation when monitoring activity in patient groups
such as the frail elderly. Ankle mounted pedometers (for
example, the StepWatch Activity Monitor and the Activity
Monitoring Pod 331) using accelerometer technology appear
to have overcome the problems identified with waist worn
devices, and research has shown such devices to be valid and
reliable irrespective of walking speed and obesity.11 18–20
The activPAL professional physical activity monitor (PAL
Technologies Ltd, Glasgow, Scotland) is a single unit device,
requiring no calibration, that records step number and
instantaneous cadence for each period of walking. In
addition, the monitor identifies episodes of walking, sitting,
and standing in real time. As no validity or reliability data
exist for this physical activity monitor, the primary purpose of
this study was to evaluate the validity and reliability of the
activPAL for measuring step number and cadence. Video
analysis was used as an objective measure of step number
and cadence and was the criterion measure used for
comparison to the activPAL. In practice most clinicians use
pedometers to quantify walking, so the secondary purpose of
the study was to compare the activPAL to two commercially
available and widely used pedometers, the Yamax Digi-
Walker SW-200 and the Omron HJ-109-E.
METHODS
This study followed the procedures outlined in previous
research7 10 14 investigating the accuracy of motion sensor
devices for measuring walking. There were two sections to
this study. In the first part, participants walked at pre-
determined speeds on a treadmill and in the second part at
self selected speeds outdoors. All walking sensors were worn
simultaneously for each test. The data from the activPAL
activity monitor and the pedometers were compared to video
observation which was regarded as the criterion measure.
Participants
A convenience sample of 20 (8 male and 12 female)
individuals was recruited from the staff and student
population of Glasgow Caledonian University. Participants
ranged widely in age and BMI (table 1). The study procedure
was approved by the University’s School of Health and Social
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Care Ethics Committee, and all participants provided written
informed consent prior to commencement of the study.
Instruments
The activPAL is a small activity monitor (563.560.7 cm)
weighing 20 g worn on the anterior aspect of the thigh. It
contains a uni-axial accelerometer which responds to
gravitational acceleration as well as the acceleration resulting
from segmental movement. From the inclination of the thigh,
posture can be classified as sitting/lying, standing or walking.
In addition, lower limb movement can provide information
relating to step number and cadence. The device has a
substantial processing capacity and memory allowing activity
and posture to be recorded continuously for periods of up to
10 days. The activPAL interfaces via a USB connection with a
Windows compatible PC. The activity pattern was analysed
using proprietary algorithms (activPAL Professional Research
Edition). The software allows data to be presented in various
ways consistent with the needs of the user. The activity can
be summarised over 24 h periods in graphical and quantita-
tive formats (fig 1).
Before each walking trial, the activPAL monitors were
connected to a personal computer through a USB interface
and were synchronised with the internal computer clock.
The pedometers used in the study were the Yamax Digi-
Walker SW-200 (Yamax Corporation, Tokyo, Japan) and the
Omron HJ-109-E (OMRON HEALTHCARE UK LTD, Milton
Keynes, UK). The sensitivity of the Omron HJ-109-E was
adjusted to the middle setting. A shake test as described by
Vincent and Sidman21 was performed on all of the ped-
ometers used in the study. It was found that all pedometers
were within 3% of the actual number of shakes.
Four activPAL physical activity monitors (two on each leg)
were attached by PALstickies (double-sided hypoallergenic
hydrogel adhesive pads) to the skin on the midline of the
anterior aspect of the thigh (fig 2). Four pedometers were
attached to the waistband of each participant: one pedometer
of each brand (Yamax Digi-Walker SW-200 and Omron HJ-
109-E) was positioned according to the manufacturers’
recommendations on both the left and right sides of the
body.
Following the manufacturer’s instructions, the sensitivity
of the Omron HJ-109-E pedometers was adjusted for each
participant. With the pedometers in position and step
number cleared, each participant was asked to walk 100
steps. The step number display on the Omron HJ-109-E was
checked and if the digital display exceeded ¡4% (steps) the
sensitivity of the pedometers was adjusted. This process was
repeated until the Omron HJ-109-E displayed 100¡4 steps.
The Yamax Digi-Walker SW-200 pedometers did not require
calibration.
Treadmill walking protocol
The motorised treadmill (PPS Med, Woodway, Waukesha,
WI) was calibrated prior to testing. An emergency stop cord
was clipped on to the participant who was instructed in the
use of the treadmill. There was a 5 min familiarisation
period, during which the participant adjusted the controls on
Table 1 Characteristics of the study population
Total (n = 20) Females (n = 12) Males (n = 8)
Age (years) 34.5¡6.9 (23–48) 33.4¡6.6 (23–48) 36.0¡7.5 (24–48)
Height (m) 1.72¡0.09 (1.62–1.89) 1.67¡0.06 (1.62–1.85) 1.79¡0.08 (1.68¡1.89)
Weight (kg) 79.1¡16.2 (57.6–115.3) 73.6¡14.9 (57.6¡98.0) 87.3¡15.3 (63.7–115.3)
BMI (kg/m2) 26.8¡4.8 (20.7–36.0) 24.6¡5.3 (20.7–36.0) 27.3¡4.5 (20.8–33.7)
Values are means¡1 SD (range).
Walking Standing Sitting
0 15 30 45 60
Figure 1 A representation of the output of the activPAL for a 1 h period (0–60 min on the horizontal bar). In this figure the pattern of activity for the
participant can be seen as they change between the postures of sitting, standing, and walking. The tall bars represent walking, the medium bars
standing, and the short bars sitting/lying.
Figure 2 The monitors in position for testing. The activPAL monitor is
worn on anterior mid-thigh, and the pedometers placed on the hip with
the Omron lateral to the Yamax. Informed consent was obtained for
publication of this figure.
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the treadmill and experienced the different speeds that were
used in the study. On completion of the familiarisation
period, a chair was placed on the treadmill and the
participant sat down before data collection commenced.
This postural transition facilitated synchronisation of the
activPAL data with the video analysis. All pedometers were
reset to zero before each trial.
The participant walked on the treadmill at five different
speeds (0.90, 1.12, 1.33, 1.54, and 1.78 m/s) for 5 min at each
speed. This was in line with previous protocols.7 10 14 After
each speed the participant stopped the treadmill and sat
down on a chair, and the pedometer counts were recorded.
The pedometers were reset to zero before the participant
proceeded to the next speed. The rest time between each
period of walking was approximately 1 min. Throughout this
study a digital video recorder focussed on the participant’s
lower limbs recorded the walking activity.
Outdoor walking protocol
In the second part of this study, each participant walked
outdoors around a 500 m course on the university campus.
Three walks were undertaken, one at each of the following
self selected speeds: slow, normal, and fast. After each walk
the participant stopped and sat down on a chair and the
pedometer values were recorded. The pedometers were then
set to zero before the next walk. The time between each
walking trial was approximately 1 min. Each walk was
recorded on a digital video camera focussed on the lower
limbs by a researcher walking behind the participant.
Data analysis
On the completion of each trial, the data from the activPAL
monitors were downloaded to a PC and step number and
cadence were calculated by the proprietary software. The
video files were downloaded to a PC using Windows Movie
Maker (Version 5.1) and played on Windows Media Player.
The recordings were visually analysed and the step number
for each trial counted. The time line on the recording allowed
the observer to calculate cadence. The mean cadence for each
walk was calculated from the second, third, and fourth
minutes for both the video analysis and activPAL data record.
The video data provided the criterion values for step number
and cadence at each speed. In looking at step number, the
data from the activPAL and both brands of pedometer were
compared to observation. Only the activPAL was compared to
observation in calculating cadence as the pedometers used in
this study were unable to record this parameter.
All descriptive data are presented as mean¡SD. To
investigate device validity, the method of Bland and
Altman22 was used to assess the percentage level of
agreement between the activPAL and observation for step
number and cadence. Observation was regarded as the
criterion measure and the narrower the limits of agreement,
the more accurate the measurement device. activPAL inter-
device reliability for step number and cadence was calculated
using intraclass correlation coefficients (ICC 2,1)23 using the
software package SPSS (version 12). ICCs were also used to
determine pedometer interdevice reliability for step number.
Absolute percentage error for the activPAL monitors and
pedometers was calculated to facilitate comparison with
other studies.
RESULTS
The treadmill walking speeds were predetermined at 0.90,
1.12, 1.33, 1.56, and 1.78 m/s. The mean outdoor walking
speeds for the self selected speeds slow, normal and fast were
1.38¡0.12, 1.65¡0.12, and 1.84¡0.14 m/s, respectively.
Over the duration of the study, one session of activPAL data
was lost which represented less than 1% of the recording
Table 2 Reliability of the monitors for step number and
cadence at the various walking speeds
Speed
(m/s)
Interdevice reliability (ICC 2,1)
Omron Yamax
activPAL
(step
number)
activPAL
(cadence)
Treadmill
0.90 0.48 0.30 0.99 0.99
1.12 0.22 0.52 1.00 0.99
1.33 0.12 0.45 0.99 0.99
1.56 0.56 0.37 1.00 0.99
1.78 0.89 0.89 0.99 0.99
Outdoor
Slow 0.01 0.48 0.99 0.99
Normal 0.73 0.56 0.99 0.99
Fast 0.70 0.74 0.99 0.99
ICC, intraclass correlation coefficient.
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Figure 3 The absolute percentage error for the different devices at each
treadmill speed. The Omron data represent the mean¡1 SD of the two
Omron pedometers. The Yamax data represent the same for the two
Yamax pedometers. The activPAL data represent the same for the four
activPAL monitors.
12.0
8.0
10.0
6.0
4.0
2.0
0.0
PAL
OM
YAM
Slow Normal Fast
Speed
A
bs
ol
ut
e 
er
ro
r (
%
)
Figure 4 The absolute percentage error for the different devices at each
outdoor walking speed. The Omron data represent the mean¡1 SD of
the two Omron pedometers. The Yamax data represent the same for the
two Yamax pedometers. The activPAL data represent the same for the
four activPAL monitors.
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time. One activPAL monitor switched off before the start of a
trial which resulted in no data being recorded. No pedometer
data were lost.
Step number
The activPAL demonstrated excellent inter device reliability
(ICC (2,1)>0.99) for step number (table 2).23 As inter device
reliability was excellent for the activPAL monitors, only one
activPAL was compared to observation to assess absolute
percentage error and the level of agreement. The activPAL
monitors were numbered from 1 to 4 and number 2 was
randomly selected to be used for all the comparisons. The
reliability of the two pedometers of each brand at the
different speeds varied considerably from poor to good (ICC
(2,1) 0.01–0.89).23
Using the method of Bland and Altman, there was an
excellent level of agreement between the activPAL and
observation (table 3) for all walking speeds on both surfaces
(treadmill and outdoors). The values of absolute percentage
error for the devices are summarised in figs 3 and 4. For the
activPAL monitor, the absolute value of percentage error for
step number was less than 1% for all speeds both on the
treadmill and outdoors (table 4). The absolute percentage
error was large for both brands of pedometer at the slower
treadmill speeds and improved considerably as speed
increased (fig 3). A similar trend was shown for outdoor
walking (fig 4).
Cadence
The activPAL demonstrated excellent inter device reliability
for cadence (ICC (2,1)>0.99).23 The Bland and Altman
comparison shows excellent agreement for cadence between
observation and the activPAL monitor (table 3). The absolute
value of percentage error for cadence for the activPAL monitor
was,1.11% for all speeds both on the treadmill and outdoors
(table 4).
DISCUSSION
Walking is the primary form of physical activity undertaken
by the general public and, therefore, it is essential that any
study wishing to measure physical activity uses a valid and
reliable tool for measuring walking. The primary purpose of
this study was to evaluate the activPAL as an objective
measurement device for walking. The results indicate that
the monitor is valid and reliable for measuring step number
and cadence, with an absolute value of percentage error of
less than 1.2% for both these parameters regardless of
walking speed and surface. The accuracy for measuring step
number is comparable to that reported for the Step Watch
activity monitor which has been shown previously to be a
very accurate walking measurement device.18 19
The results for the pedometers revealed poor inter device
reliability and poor agreement for step numbers at slow
speeds. These findings concur with previous studies.16 17 24
In this study the BMI of participants ranged widely
(table 1) with five individuals possessing a BMI.30 kg/m2,
the clinical classification of obese. While investigating the
effect of obesity on the accuracy of the activPAL was not the
focus of the study, the low absolute percentage error values
for all participants suggest that the monitor accuracy is not
adversely affected by obesity. However, as the number of
obese individuals was low, further research may be needed to
confirm these observations.
The positive effects of physical activity are well documen-
ted and guidelines quantifying the amount of exercise needed
to achieve health benefits have been published. In translating
the guidelines into practice, it is essential to consider the
dose-response relationship between activity and health.25–27
In order to encourage a person to be active, the activity must
Table 3 The percentage agreement for step number and cadence between observation and the activPAL monitor
Speed (m/s)
Step number Cadence
Observation
(step number)
Mean
difference (%) ULOA (%) LLOA (%)
Observation
(step number)
Mean
difference (%) ULOA (%) LLOA (%)
Treadmill
0.90 498¡42 0.94 1.87 0.01 93¡8 0.80 3.10 21.40
1.12 555¡44 0.59 1.13 0.06 103¡7 0.76 2.65 21.12
1.33 590¡48 0.50 1.18 20.18 110¡7 0.70 3.20 21.80
1.56 622¡45 0.44 1.08 20.20 118¡7 0.80 3.20 21.50
1.78 666¡45 0.63 1.89 20.63 127¡7 0.99 2.60 20.63
Outdoor
Normal 608¡44 20.02 1.15 21.18 121¡8 0.90 3.20 21.30
Slow 653¡40 0.06 1.17 21.05 112¡8 0.30 2.60 22.00
Fast 579¡41 0.18 1.39 21.03 128¡7 0.10 2.90 22.60
LLOA, lower limit of agreement; ULOA, upper limit of agreement. Step number and cadence are presented as means¡1 SD.
Table 4 The absolute percentage error for step number and cadence for the activPAL physical activity monitor at the various
walking speeds
Speed (m/s)
Actual step no.
(step number) % Error
Actual cadence
(step number/min) % Error
Treadmill
0.9 498¡42 0.94¡0.47 93¡8 0.93¡1.05
1.12 555¡44 0.59¡0.27 103¡7 0.86¡0.86
1.33 590¡48 0.53¡0.28 110¡7 1.08¡0.94
1.56 622¡45 0.47¡0.27 118¡7 1.09¡0.96
1.78 666¡45 0.66¡0.60 127¡7 1.06¡0.71
Outdoor
Normal 608¡44 0.37¡0.47 121¡8 1.11¡0.97
Slow 653¡40 0.42¡0.37 112¡8 1.01¡0.63
Fast 579¡41 0.47¡0.43 128¡7 1.03¡0.94
Values are means¡1 SD.
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be perceived to be feasible and the minimum dosage for
health benefits established. When quantifying activity, dose
is related to the duration, frequency, intensity, and mode.26 In
walking, duration can be determined by a daily total of step
number, time, or distance. Frequency relates to the number
of walking episodes per day and intensity is indicated by
cadence or speed. The different elements of walking as an
activity (duration, frequency, and intensity) are also of
clinical interest. Although a daily total (step number,
distance, or time) may provide useful information, it may
be more relevant to a clinician to know if this is accumulated
from one long walk or multiple short walks. In combating
sedentary behaviour, frequent short walks may be recom-
mended. However, lengthy periods of walking may be
advocated when increasing endurance. Consequently, mea-
surement devices that are able to record all of these
parameters are valuable. This study identifies the activPAL
as such a device and considering it is unaffected by walking
speed or BMI, it may prove a useful tool, not only in healthy
groups but in elderly and clinical populations. The main
disadvantage of accelerometer based monitors, including the
activPAL, is their relatively high cost when compared to waist
mounted pedometers. However, this has to be balanced
against the quality and detail of information provided by
these devices.
This study focussed on the performance of the device with
healthy adults walking at a wide range of cadences, and
showed consistently good performance across all testing
conditions. However, it is possible that the activPAL may not
perform as well with other populations, such as the frail
elderly or young children, as the algorithms used may be
favoured towards the gait of healthy adults. For example,
frail elderly adults may walk with a hesitant, slow gait
different to that of a healthy population. As with all such
devices, further testing in these groups would be required.
The total duration of testing, for each participant, was
approximately 40 min, which was a small percentage of the
monitor’s full time recording capability of 10 days. This
methodology is consistent with other similar studies in the
literature,7 10 14 but testing overall performance of the device
over a longer period may be warranted.
It is acknowledged that treadmill walking is not represen-
tative of normal walking, which may be a limitation of the
study. However, it is useful to evaluate ambulatory monitors
at controlled walking speeds. The outdoor free-walking
section of this study allowed the monitor to be tested under
normal walking conditions as the route required subjects to
negotiate curbs, small slopes, road crossings, and limited
traffic within the university campus.
CONCLUSION
The activPAL has been shown to be a valid and reliable device
for measuring step number and cadence in a healthy adult
population. The monitor performed equally well in outdoor
and treadmill trials. The accuracy of the monitor was
unaffected by walking speed.
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Who said that?
‘‘In questions of science, the authority of a thousand is not worth the humble reasoning of a
single individual.’’
‘‘Measure what is measurable, and make measurable what is not so. I do not feel obliged to
believe that the same God who endowed us with sense, reason, and intellect intended us to
forgo their use.’’
‘‘All truths are easy to understand once they are discovered; the point is to discover them.
Infinities and indivisibles transcend our finite understanding, the former on account of their
magnitude, the latter because of their smallness; imagine what they are when combined.’’
‘‘I have never met a man so ignorant that I could not learn something from him.’’
‘‘And who can doubt that it will lead to the worst disorders when minds created free by God
are compelled to submit slavishly to an outside will?...when people devoid of whatsoever
competence are made judges over experts and are granted authority to treat them as they
please? These are the novelties which are apt to bring about the ruin of commonwealths and
the subversion of the state.’’ (Written on the margin of his own copy of Dialogue on the great
world systems.)
‘‘Epur si muove. (And yet it does move)’’ (Apocryphal words to himself after making his
abjuration of heliocentricity to the Inquisition.)
See page 806 for the answer.
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